This collection requires respondents
to keep specific records as identified in 21 CFR part 589, and
establishes reporting provisions for those respondents seeking to
be designated as not subject to specific restrictions as stated in
the regulations. The information collection supports regulatory
measures that will help FDA prevent BSE from infiltrating animal
food or feed. Respondents are persons that manufacture, blend,
process and distribute products that contain or may contain protein
derived from mammalian tissue, and feeds made from such
products.
The total burden for this
collection has been adjusted to reflect a decrease in the number of
submissions to the agency. This adjustment is discussed more fully
at Q15 of the agency's supporting statement, part A.
$3,350
No
No
No
No
No
Uncollected
Domini Bean 301 796-5733
domini.bean@fda.hhs.gov
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.